Structures published

Total: 76

Creatine monohydrate

C₄H₉N₃O_2,H₂O₁

Frampton, Christopher S.Wilson, Chick C.Shankland, Norman Florence, Alastair J.

Journal of the Chemical Society, Faraday Transactions (1997) 93, 10 1875-1879

a=12.489(7)Å b=4.987(1)Å c=12.075(6)Å

α=90° β=108.86(3)° γ=90°

Creatine monohydrate

C₄H₉N₃O_2,H₂O₁

C.S.Frampton C.C.Wilson N.Shankland A.J.Florence

J.Chem.Soc.,Faraday Trans. (1997) 93, 1875

a=12.492(4)Å b=4.967(1)Å c=12.051(4)Å

α=90° β=109.10(2)° γ=90°

Zopiclone

C₁₇ClN₆O₃

Shankland, N.David, W. I.Shankland, K.Kennedy, A. R.Frampton, C. S.Florence, A. J.

Chemical communications (Cambridge, England) (2001) 21 2204-2205

a=15.2023(4)Å b=7.1510(1)Å c=17.6577(3)Å

α=90.0° β=111.213(1)° γ=90.0°

Zopiclone dihydrate

C₁₇ClN₆O_3,2(O)

Shankland, N.David, W. I.Shankland, K.Kennedy, A. R.Frampton, C. S.Florence, A. J.

Chemical communications (Cambridge, England) (2001) 21 2204-2205

a=16.4834(1)Å b=7.1465(1)Å c=17.4026(1)Å

α=90.0° β=109.8065(4)° γ=90.0°

Zopiclone

C₁₇ClN₆O₃

Shankland, N.David, W. I.Shankland, K.Kennedy, A. R.Frampton, C. S.Florence, A. J.

Chemical communications (Cambridge, England) (2001) 21 2204-2205

a=5.5813(1)Å b=8.8467(1)Å c=35.6588(3)Å

α=90.0° β=90.0° γ=90.0°

Zopiclone

C₁₇H₁₇ClN₆O₃

Shankland, N.David, W. I.Shankland, K.Kennedy, A. R.Frampton, C. S.Florence, A. J.

Chemical communications (Cambridge, England) (2001) 21 2204-2205

a=5.50540(10)Å b=8.7686(2)Å c=35.5277(7)Å

α=90.00° β=90.00° γ=90.00°

Zopiclone

C₁₇H₁₇ClN₆O₃

Shankland, N.David, W. I.Shankland, K.Kennedy, A. R.Frampton, C. S.Florence, A. J.

Chemical communications (Cambridge, England) (2001) 21 2204-2205

a=5.50230(10)Å b=8.7676(2)Å c=35.5314(7)Å

α=90.00° β=90.00° γ=90.00°

Zopiclone dihydrate

C₁₇H₂₁ClN₆O₅

Shankland, N.David, W. I.Shankland, K.Kennedy, A. R.Frampton, C. S.Florence, A. J.

Chemical communications (Cambridge, England) (2001) 21 2204-2205

a=16.374(4)Å b=7.030(3)Å c=17.185(2)Å

α=90° β=108.62(1)° γ=90°

C₇H₇N₃O₄

C₇H₇N₃O₄

Graham, Duncan Kennedy, Alan R.McHugh, Callum J.Smith, W. Ewen David, William I. F.Shankland, Kenneth Shankland, Norman

New Journal of Chemistry (2004) 28, 1 161

a=8.0136(3)Å b=8.0502(3)Å c=14.2752(5)Å

α=75.097(2)° β=74.059(2)° γ=78.453(2)°

C₇H₇N₃O₅

C₇H₇N₃O₅

Graham, Duncan Kennedy, Alan R.McHugh, Callum J.Smith, W. Ewen David, William I. F.Shankland, Kenneth Shankland, Norman

New Journal of Chemistry (2004) 28, 1 161

a=15.0980(4)Å b=3.9219(1)Å c=16.4446(5)Å

α=90.00° β=116.586(2)° γ=90.00°

C₇H₇N₃O₄

C₇H₇N₃O₄

Graham, Duncan Kennedy, Alan R.McHugh, Callum J.Smith, W. Ewen David, William I. F.Shankland, Kenneth Shankland, Norman

New Journal of Chemistry (2004) 28, 1 161

a=6.7072(5)Å b=16.0387(11)Å c=8.1083(5)Å

α=90.00° β=91.160(4)° γ=90.00°

4-Chlorobenzoic acid

C₇H₅ClO₂

Wilson, Chick C.Xu, Xuelian Florence, Alastair J.Shankland, Norman

New Journal of Chemistry (2006) 30, 7 979

a=14.368(9)Å b=6.132(4)Å c=3.778(2)Å

α=87.46(5)° β=100.50(4)° γ=92.94(4)°

4-Chlorobenzoic acid

C₇H₅ClO₂

Wilson, Chick C.Xu, Xuelian Florence, Alastair J.Shankland, Norman

New Journal of Chemistry (2006) 30, 7 979

a=14.210(6)Å b=6.072(2)Å c=3.747(1)Å

α=87.68(3)° β=100.32(3)° γ=93.00(3)°

4-Chlorobenzoic acid

C₇H₅ClO₂

Wilson, Chick C.Xu, Xuelian Florence, Alastair J.Shankland, Norman

New Journal of Chemistry (2006) 30, 7 979

a=14.220(6)Å b=6.087(2)Å c=3.766(1)Å

α=87.91(4)° β=100.22(3)° γ=92.97(3)°

4-Chlorobenzoic acid

C₇H₅ClO₂

Wilson, Chick C.Xu, Xuelian Florence, Alastair J.Shankland, Norman

New Journal of Chemistry (2006) 30, 7 979

a=14.209(7)Å b=6.120(2)Å c=3.794(1)Å

α=88.31(4)° β=100.19(4)° γ=93.03(3)°

C₅₂H₄₈N₂O₄

C₅₂H₄₈N₂O₄

Monika Warzecha Jesus Calvo-Castro Alan R. Kennedy Alisdair N. Macpherson Kenneth Shankland Norman Shankland Andrew J. McLean Callum J. McHugh

Chem.Commun. (2015) 51, 1143

a=20.5116(14)Å b=5.1146(4)Å c=21.4898(15)Å

α=90.00° β=116.490(2)° γ=90.00°

C₁₇H₁₇FN₃O_3,5(H₂O)_,NA

C₁₇H₁₇FN₃O_3,5(H₂O)_,NA

Fabbiani, Francesca P. A.Dittrich, Birger Florence, Alastair J.Gelbrich, Thomas Hursthouse, Michael B.Kuhs, Werner F.Shankland, Norman Sowa, Heidrun

CrystEngComm (2009) 11, 7 1396

a=9.624(3)Å b=9.493(3)Å c=11.471(4)Å

α=89.643(6)° β=103.304(6)° γ=88.861(6)°

Ciprofloxacin

C₁₇H₁₈FN₃O₃

Fabbiani, Francesca P. A.Dittrich, Birger Florence, Alastair J.Gelbrich, Thomas Hursthouse, Michael B.Kuhs, Werner F.Shankland, Norman Sowa, Heidrun

CrystEngComm (2009) 11, 7 1396

a=7.9606(2)Å b=8.5798(2)Å c=10.7739(3)Å

α=87.868(3)° β=85.153(2)° γ=88.212(1)°

2(C₁₇H₁₇FN₃O₃)_,10(H₂O)_,2(Na)

2(C₁₇H₁₇FN₃O₃)_,10(H₂O)_,2(Na)

Fabbiani, Francesca P. A.Dittrich, Birger Florence, Alastair J.Gelbrich, Thomas Hursthouse, Michael B.Kuhs, Werner F.Shankland, Norman Sowa, Heidrun

CrystEngComm (2009) 11, 7 1396

a=11.065(10)Å b=13.155(12)Å c=13.879(12)Å

α=90.983(14)° β=98.941(14)° γ=93.181(14)°

C₁₇H_17.50F₁N₃O_3,Na_0.50,5(H₂O)

C₁₇H_17.50F₁N₃O_3,Na_0.50,5(H₂O)

Fabbiani, Francesca P. A.Dittrich, Birger Florence, Alastair J.Gelbrich, Thomas Hursthouse, Michael B.Kuhs, Werner F.Shankland, Norman Sowa, Heidrun

CrystEngComm (2009) 11, 7 1396

a=9.452(3)Å b=9.591(4)Å c=11.233(6)Å

α=85.67(2)° β=99.62(2)° γ=93.74(2)°

C₁₇H₁₇FN₃O_3,5(H₂O)_,NA

C₁₇H₁₇FN₃O_3,5(H₂O)_,NA

Fabbiani, Francesca P. A.Dittrich, Birger Florence, Alastair J.Gelbrich, Thomas Hursthouse, Michael B.Kuhs, Werner F.Shankland, Norman Sowa, Heidrun

CrystEngComm (2009) 11, 7 1396

a=9.547(7)Å b=9.870(7)Å c=11.109(12)Å

α=88.79(4)° β=101.42(4)° γ=90.25(2)°

C₁₇H_17.50F₁N₃O_3,Na_0.50,5(H₂O)

C₁₇H_17.50F₁N₃O_3,Na_0.50,5(H₂O)

Fabbiani, Francesca P. A.Dittrich, Birger Florence, Alastair J.Gelbrich, Thomas Hursthouse, Michael B.Kuhs, Werner F.Shankland, Norman Sowa, Heidrun

CrystEngComm (2009) 11, 7 1396

a=9.391(8)Å b=9.570(8)Å c=11.095(9)Å

α=85.247(14)° β=99.498(13)° γ=93.272(14)°

5H-dibenz(b,f)azepine-5-carboxamide 10,11-dihydro-5H- dibenz(b,f)azepine-5-carboxamide (1/1)

0.5(C₁₅H₁₂N₂O₁)_,0.5(C₁₅H₁₄N₂O₁)

Florence, A. J.Leech, C. K.Shankland, N.Shankland, K.Johnston, A.

CrystEngComm (2006) 8, 10 746

a=9.088(2)Å b=10.425(4)Å c=25.005(7)Å

α=90.00° β=90.00° γ=90.00°

10,11-Dihydro-5H-dibenzo(a,d)cycloheptene-5-carboxamide

C₁₆H₁₅NO

Florence, A. J.Shankland, K.Gelbrich, T.Hursthouse, M. B.Shankland, N.Johnston, A.Fernandes, P.Leech, C. K.

CrystEngComm (2008) 10, 1 26

a=5.6491(1)Å b=19.5639(4)Å c=22.0741(5)Å

α=84.2178(13)° β=88.4073(14)° γ=83.6001(13)°

Cytenamide form II

C₁₆H₁₃N₁O₁

Florence, A. J.Bedford, C. T.Fabbiani, F. P. A.Shankland, K.Gelbrich, T.Hursthouse, M. B.Shankland, N.Johnston, A.Fernandes, P.

CrystEngComm (2008) 10, 7 811

a=5.8100(2)Å b=19.6315(5)Å c=21.7087(6)Å

α=85.918(2)° β=86.164(2)° γ=84.482(2)°

Cytenamide form I

C₁₆H₁₃N₁O₁

Florence, A. J.Bedford, C. T.Fabbiani, F. P. A.Shankland, K.Gelbrich, T.Hursthouse, M. B.Shankland, N.Johnston, A.Fernandes, P.

CrystEngComm (2008) 10, 7 811

a=33.9078(10)Å b=33.9078(10)Å c=5.6754(2)Å

α=90° β=90° γ=120°

5H-dibenz(b,f)azepine-5-carboxamide 2-(1-((4- chlorophenyl)carbonyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid (1/1)

C₁₅H₁₂N₂O_1,C₁₉H₁₆Cl₁N₁O₄

Majumder, Mridul Buckton, Graham Rawlinson-Malone, Clare Williams, Adrian C.Spillman, Mark J.Shankland, Norman Shankland, Kenneth

CrystEngComm (2011) 13, 21 6327

a=10.2447(3)Å b=29.148(1)Å c=10.2114(3)Å

α=90° β=106.636(2)° γ=90°

4-Chlorobenzoic acid

C₇H₅ClO₂

Wilson, Chick C.Xu, Xuelian Florence, Alastair J.Shankland, Norman

New Journal of Chemistry (2006) 30, 7 979

a=14.272(8)Å b=6.141(3)Å c=3.813(2)Å

α=88.53(4)° β=100.11(4)° γ=93.18(3)°

C₉H₁₇NO_2,7(H₂O)

C₉H₁₇NO_2,7(H₂O)

Fabbiani, Francesca P. A.Levendis, Demetrius C.Buth, Gernot Kuhs, Werner F.Shankland, Norman Sowa, Heidrun

CrystEngComm (2010) 12, 8 2354

a=6.7906(12)Å b=7.3159(4)Å c=15.8428(14)Å

α=86.297(6)° β=78.924(11)° γ=72.713(6)°

Αβ-<i>D</i>-Lactose

C₁₂H₂₂O₁₁

Nicholls, Daniel Elleman, Carole Shankland, Norman Shankland, Kenneth

Acta Crystallographica Section C (2019) 75, 7

a=5.0044(3)Å b=38.6364(14)Å c=7.6007(4)Å

α=90° β=106.200(5)° γ=90°

C₇D₁₆N₁O_2,Br

C₇D₁₆N₁O_2,Br

Shankland, N.Florence, A. J.Wilson, C. C.

Acta Crystallographica Section B (1997) 53, 1 176-180

a=10.951(4)Å b=13.396(8)Å c=7.072(4)Å

α=90° β=108.88(3)° γ=90°

6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide

C₇H₆ClN₃O₄S₂

Fernandes, P.Shankland, K.David, W. I. F.Markvardsen, A. J.Florence, A. J.Shankland, N.Leech, C. K.

Journal of Applied Crystallography (2008) 41, 6 1089-1094

a=4.8481(16)Å b=6.359(2)Å c=8.900(3)Å

α=74.49(3)° β=83.90(3)° γ=80.53(3)°

6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide

C₇H₆ClN₃O₄S₂

Fernandes, P.Shankland, K.David, W. I. F.Markvardsen, A. J.Florence, A. J.Shankland, N.Leech, C. K.

Journal of Applied Crystallography (2008) 41, 6 1089-1094

a=4.8619(17)Å b=6.377(2)Å c=8.926(3)Å

α=74.40(3)° β=83.93(3)° γ=80.56(3)°

6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide

C₇H₆ClN₃O₄S₂

Fernandes, P.Shankland, K.David, W. I. F.Markvardsen, A. J.Florence, A. J.Shankland, N.Leech, C. K.

Journal of Applied Crystallography (2008) 41, 6 1089-1094

a=4.8737(9)Å b=6.4046(13)Å c=8.9548(16)Å

α=74.324(17)° β=83.751(15)° γ=80.449(16)°

6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide

C₇H₆ClN₃O₄S₂

Fernandes, P.Shankland, K.David, W. I. F.Markvardsen, A. J.Florence, A. J.Shankland, N.Leech, C. K.

Journal of Applied Crystallography (2008) 41, 6 1089-1094

a=4.8707(9)Å b=6.3951(12)Å c=8.9448(16)Å

α=74.368(16)° β=83.786(14)° γ=80.459(15)°

6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide

C₇H₆ClN₃O₄S₂

Fernandes, P.Shankland, K.David, W. I. F.Markvardsen, A. J.Florence, A. J.Shankland, N.Leech, C. K.

Journal of Applied Crystallography (2008) 41, 6 1089-1094

a=4.8786(9)Å b=6.4126(13)Å c=8.9665(16)Å

α=74.266(16)° β=83.693(15)° γ=80.445(16)°

Famotidine

C₈H₁₅N₇O₂S₃

Shankland, Kenneth McBride, Lorraine David, William I. F.Shankland, Norman Steele, Gerald

Journal of Applied Crystallography (2002) 35, 4 443-454

a=17.6547(4)Å b=5.29320(10)Å c=18.2590(3)Å

α=90.0° β=123.5580(10)° γ=90.0°

N-[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]- 3-[2-(2-naphthalen-1-ylethoxy)ethylsulfonyl]propylaminium benzoate

C₂₆H₃₁N₂O₅S_2,C₇H₅O₂

Johnston, Andrea Florence, Alastair J.Shankland, Kenneth Markvardsen, Anders Shankland, Norman Steele, Gerald Cosgrove, Stephen D.

Acta Crystallographica Section E (2004) 60, 10 o1751-o1753

a=7.63122(17)Å b=13.6673(3)Å c=15.8058(5)Å

α=84.385(2)° β=87.4653(19)° γ=75.7135(13)°

Chlorothiazide dimethylformamide solvate

C₇H₆ClN₃O₄S_2,C₃H₇NO

Fernandes, Philippe Florence, Alastair J.Shankland, Kenneth Shankland, Norman Johnston, Andrea

Acta Crystallographica Section E (2006) 62, 6 o2216-o2218

a=7.9822(4)Å b=8.8830(5)Å c=11.1075(6)Å

α=86.689(3)° β=75.078(3)° γ=73.196(3)°

4-Chlorobenzoic acid N,N-dimethylformamide solvate

C₇H₅ClO_2,C₃H₇NO

Xu, Xuelian Kennedy, Alan R.Florence, Alastair J.Shankland, Norman

Acta Crystallographica Section E (2004) 60, 11 o1950-o1951

a=6.1269(2)Å b=14.6159(5)Å c=12.6541(4)Å

α=90.00° β=103.228(2)° γ=90.00°

2-amino-5-nitrobenzophenone

C₁₃H₁₀N₂O₃

Philip J. Cox Abu T. Md. Anisuzzaman R. Howard Pryce-Jones Graham G. Skellern Alastair J. Florence Norman Shankland

Acta Crystallographica Section C (1998) 54, 6 856-859

a=5.7358(15)Å b=14.693(2)Å c=13.1120(12)Å

α=90.00° β=98.87(4)° γ=90.00°

2-methylamino-9-fluoro-5-nitrobenzophenone

C₁₄H₁₁FN₂O₃

Philip J. Cox Abu T. Md. Anisuzzaman R. Howard Pryce-Jones Graham G. Skellern Alastair J. Florence Norman Shankland

Acta Crystallographica Section C (1998) 54, 6 856-859

a=4.2150(17)Å b=13.6020(18)Å c=21.547(7)Å

α=90.00° β=94.7480(11)° γ=90.00°

2-Methylamino-5-chlorobenzophenone

C₁₄H₁₂ClNO

Cox, P. J.Anisuzzaman, A. T. Md.Skellern, G. G.Pryce-Jones, R. H.Florence, A. J.Shankland, N.

Acta Crystallographica Section C (1997) 53, 4 476-477

a=12.928(5)Å b=5.546(5)Å c=16.445(5)Å

α=90° β=92.392(5)° γ=90°

Ibuprofen

C₁₃H₁₈O₂

Shankland, Norman Wilson, Chick C.Florence, Alastair J.Cox, Philip J.

Acta Crystallographica Section C (1997) 53, 951-954

a=14.397(8)Å b=7.818(4)Å c=10.506(6)Å

α=90° β=99.70(3)° γ=90°

2-(2-amino-5-bromobenzoyl)pyridine

BrC~6~H~3~NH~2~COC~5~H~4~N

Cox, P. J.Anisuzzaman, A. T. Md.Pryce-Jones, R. H.Shankland, N.Skellern, G. G.

Acta Crystallographica Section C (1996) 52, 4 929-931

a=3.888(3)Å b=9.984(4)Å c=27.537(8)Å

α=90° β=93.09(8)° γ=90°

C₁₃H₁₈O₂

C₁₃H₁₈O₂

Freer, A. A.Bunyan, J. M.Shankland, N.Sheen, D. B.

Acta Crystallographica Section C (1993) 49, 7 1378-1380

a=12.462(3)Å b=8.035(3)Å c=13.539(4)Å

α=90.° β=112.89(3)° γ=90.°

1,3-diphenyl-4-imidazoline-2-thione

C₁₅H₁₂N₂S

Cox, P. J.Sohal, B.Skellern, G. G.Love, S. W.Shankland, N.

Acta Crystallographica Section C (1996) 52, 12 3152-3154

a=12.454(7)Å b=11.382(8)Å c=17.841(7)Å

α=90.00° β=90.00° γ=90.00°

C₅H₁₀N₂O₃S

C₅H₁₀N₂O₃S

Kennedy, Alan R.Skellern, Graham G.Pfirrmann, Rolf W.Smail, Gordon A.Shankland, Norman Florence, Alastair J.

Acta Crystallographica Section C (1999) 55, 2 232-234

a=9.088(2)Å b=8.108(2)Å c=10.505(2)Å

α=90° β=102.140(10)° γ=90°

C₁₂H₂₄N₆O₆S₃

C₁₂H₂₄N₆O₆S₃

Kennedy, Alan R.Skellern, Graham G.Pfirrmann, Rolf W.Smail, Gordon A.Shankland, Norman Florence, Alastair J.

Acta Crystallographica Section C (1999) 55, 2 232-234

a=14.5300(10)Å b=8.0567(8)Å c=15.928(2)Å

α=90° β=101.642(8)° γ=90°

Trichlormethiazide

C₈H₈Cl₃N₃O₄S₂

Fernandes, Philippe Leech, Charlotte K.Johnston, Andrea Shankland, Kenneth David, William I. F.Shankland, Norman Florence, Alastair J.

Acta Crystallographica Section E (2007) 63, 9 o3685-o3685

a=8.7881(2)Å b=9.7924(2)Å c=15.8527(3)Å

α=90.00° β=90.00° γ=90.00°

Dihydrocarbamazepine formamide

C₁₅H₁₄N₂O_,CH₃NO

Johnston, Andrea Florence, Alastair J.Fernandes, Philippe Shankland, Norman Kennedy, Alan R.

Acta Crystallographica Section E (2007) 63, 9 o3888-o3889

a=8.4690(4)Å b=9.0215(4)Å c=10.3137(4)Å

α=74.363(3)° β=83.630(3)° γ=70.847(3)°

10,11-Dihydrocarbamazepine--dimethyl sulfoxide (1/1)

C₁₅H₁₄N₂O_1,C₂H₆OS

Johnston, Andrea Florence, Alastair J.Shankland, Kenneth Leech, Charlotte K.Shankland, Norman Fernandes, Philippe

Acta Crystallographica Section E (2007) 63, 9 o3918-o3919

a=10.2696(3)Å b=6.8543(2)Å c=23.3599(6)Å

α=90.00° β=98.932(2)° γ=90.00°

Dihydrocarbamazepine Form III

C₁₅H₁₄N₂O₁

Leech, Charlotte K.Florence, Alastair J.Shankland, Kenneth Shankland, Norman Johnston, Andrea

Acta Crystallographica Section E (2007) 63, 2 o675-o677

a=5.4233(12)Å b=9.200(5)Å c=24.189(6)Å

α=87.59(3)° β=84.23(2)° γ=88.93(3)°

10,11-Dihydrocarbamazepine--formic acid (1/1)

C₁₅H₁₄N₂O_,CH₂O₂

Johnston, Andrea Florence, Alastair J.Fernandes, Philippe Shankland, Norman Kennedy, Alan R.

Acta Crystallographica Section E (2007) 63, 3 o1469-o1470

a=5.2298(4)Å b=9.3849(12)Å c=14.4858(18)Å

α=83.853(5)° β=88.230(7)° γ=88.221(7)°

10,11-Dihydrocarbamazepine--acetic acid (1/1)

C₁₅H₁₄N₂O_,C₂H₄O₂

Johnston, Andrea Florence, Alastair J.Fernandes, Philippe Shankland, Norman Kennedy, Alan R.

Acta Crystallographica Section E (2006) 62, 12 o5361-o5362

a=5.3104(4)Å b=15.4246(17)Å c=18.732(2)Å

α=90.00° β=95.106(7)° γ=90.00°

Cyheptamide

C₁₆H₁₅NO

Leech, Charlotte K.Florence, Alastair J.Shankland, Kenneth Shankland, Norman Johnston, Andrea

Acta Crystallographica Section E (2007) 63, 1 o205-o206

a=5.6035(7)Å b=9.1716(11)Å c=23.579(3)Å

α=90.00° β=96.752(12)° γ=90.00°

Bendroflumethiazide acetone solvate

C₁₅H₁₄F₃N₃O₄S_2,C₃H₆O

Fabbiani, Francesca P. A.Leech, Charlotte K.Shankland, Kenneth Johnston, Andrea Fernandes, Philippe Florence, Alastair J.Shankland, Norman

Acta Crystallographica Section C (2007) 63, 11 o659-o663

a=8.192(2)Å b=9.525(2)Å c=14.101(2)Å

α=99.538(17)° β=100.171(17)° γ=100.42(2)°

Bendroflumethiazide N,N-dimethylformamide solvate

C₁₅H₁₄F₃N₃O₄S_2,C₃H₇NO

Fabbiani, Francesca P. A.Leech, Charlotte K.Shankland, Kenneth Johnston, Andrea Fernandes, Philippe Florence, Alastair J.Shankland, Norman

Acta Crystallographica Section C (2007) 63, 11 o659-o663

a=8.2527(3)Å b=17.8431(7)Å c=14.9012(5)Å

α=90° β=103.752(4)° γ=90°

Norfloxacin dihydrate

C₁₆H₁₈FN₃O_3,2H₂O

Florence, Alastair J.Kennedy, Alan R.Shankland, Norman Wright, Elaine Al-Rubayi, Ayad

Acta Crystallographica Section C (2000) 56, 11 1372-1373

a=8.265(3)Å b=21.698(4)Å c=9.5250(17)Å

α=90.00° β=110.794(19)° γ=90.00°

C₁₀H₉N_2,C₄HO₄

C₁₀H₉N_2,C₄HO₄

David M. S. Martins Derek S. Middlemiss Colin R. Pulham Chick C. Wilson Mark T. Weller Paul F. Henry Norman Shankland Kenneth Shankland William G. Marshall Richard M. Ibberson Kevin Knight Stephen Moggach Michela Brunelli Carole A. Morrison

Journal of the American Chemical Society (2009) 131, 3884-3893

a=3.7551(5)Å b=11.2066(13)Å c=27.322(3)Å

α=90° β=92.947(7)° γ=90°

C₁₀H₉N_2,C₄HO₄

C₁₀H₉N_2,C₄HO₄

David M. S. Martins Derek S. Middlemiss Colin R. Pulham Chick C. Wilson Mark T. Weller Paul F. Henry Norman Shankland Kenneth Shankland William G. Marshall Richard M. Ibberson Kevin Knight Stephen Moggach Michela Brunelli Carole A. Morrison

Journal of the American Chemical Society (2009) 131, 3884-3893

a=3.79750(10)Å b=11.1996(3)Å c=27.4424(7)Å

α=90° β=92.236(2)° γ=90°

C₁₀H₉N_2,C₄HO₄

C₁₀H₉N_2,C₄HO₄

David M. S. Martins Derek S. Middlemiss Colin R. Pulham Chick C. Wilson Mark T. Weller Paul F. Henry Norman Shankland Kenneth Shankland William G. Marshall Richard M. Ibberson Kevin Knight Stephen Moggach Michela Brunelli Carole A. Morrison

Journal of the American Chemical Society (2009) 131, 3884-3893

a=12.359(8)Å b=11.287(7)Å c=9.061(6)Å

α=90° β=109.139(10)° γ=90°

C₅₆H₄₀N₈O₁₆

C₅₆H₄₀N₈O₁₆

Martins, David M. S.Middlemiss, Derek S.Pulham, Colin R.Wilson, Chick C.Weller, Mark T.Henry, Paul F.Shankland, Norman Shankland, Kenneth Marshall, William G.Ibberson, Richard M.Knight, Kevin Moggach, Stephen Brunelli, Michela Morrison, Carole A.

Journal of the American Chemical Society (2009) 131, 11 3884-3893

a=12.4300(27)Å b=11.2743(12)Å c=9.0678(22)Å

α=90.000° β=109.488(14)° γ=90.000°

Remacemide

C₁₇H₂₀N₂O

Lewis, Gareth R.Steele, Gerry McBride, Lorraine Florence, Alastair J.Kennedy, Alan R.Shankland, Norman David, William I. F.Shankland, Kenneth Teat, Simon J.

Crystal Growth & Design (2005) 5, 2 427

a=8.9200(10)Å b=16.524(2)Å c=9.8570(10)Å

α=90.00° β=93.836(10)° γ=90.00°

Remacemide nitrate

C₁₇H₂₁N₂O_1,N₁O₃

Lewis, Gareth R.Steele, Gerry McBride, Lorraine Florence, Alastair J.Kennedy, Alan R.Shankland, Norman David, William I. F.Shankland, Kenneth Teat, Simon J.

Crystal Growth & Design (2005) 5, 2 427

a=11.724(4)Å b=8.932(4)Å c=15.872(4)Å

α=90.00° β=95.93(2)° γ=90.00°

Remacemide xinafoate

C₁₇H₂₁N₂O_1,C₁₁H₇O₃

Lewis, Gareth R.Steele, Gerry McBride, Lorraine Florence, Alastair J.Kennedy, Alan R.Shankland, Norman David, William I. F.Shankland, Kenneth Teat, Simon J.

Crystal Growth & Design (2005) 5, 2 427

a=11.9187(10)Å b=31.801(3)Å c=7.9304(7)Å

α=90.00° β=128.382(2)° γ=90.00°

Remacemide acetate

C₁₇H₂₁N₂O_1,C₂H₃O₂

Lewis, Gareth R.Steele, Gerry McBride, Lorraine Florence, Alastair J.Kennedy, Alan R.Shankland, Norman David, William I. F.Shankland, Kenneth Teat, Simon J.

Crystal Growth & Design (2005) 5, 2 427

a=15.4018(3)Å b=6.7683(1)Å c=17.3531(3)Å

α=90.0° β=93.13(1)° γ=90.0°

Remacemide napsilate

C₁₇H₂₁N₂O_1,C₁₀H₇SO_3,0.4(C₂H₆O₁)_,0.5(H₂O₁)

Lewis, Gareth R.Steele, Gerry McBride, Lorraine Florence, Alastair J.Kennedy, Alan R.Shankland, Norman David, William I. F.Shankland, Kenneth Teat, Simon J.

Crystal Growth & Design (2005) 5, 2 427

a=9.7297(4)Å b=14.4323(3)Å c=19.4269(4)Å

α=104.859(2)° β=90.490(2)° γ=95.546(2)°

C₁₅H₁₃ClN₂O

C₁₅H₁₃ClN₂O

Buist, Amanda R.Kennedy, Alan R.Shankland, Kenneth Shankland, Norman Spillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=7.6241(3)Å b=9.5476(4)Å c=17.8401(7)Å

α=90.00° β=90.00° γ=90.00°

C₁₅H₁₃BrN₂O

C₁₅H₁₃BrN₂O

Buist, Amanda R.Kennedy, Alan R.Shankland, Kenneth Shankland, Norman Spillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=5.3472(2)Å b=10.3235(3)Å c=49.6238(17)Å

α=90.00° β=90.00° γ=90.00°

C₁₆H_16.6Cl_0.4NO_2.6

C₁₆H_16.6Cl_0.4NO_2.6

Buist, Amanda R.Kennedy, Alan R.Shankland, Kenneth Shankland, Norman Spillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=20.2651(9)Å b=5.8463(3)Å c=23.8489(9)Å

α=90.00° β=95.724(4)° γ=90.00°

C₁₅H₁₅BrN₂O₂

C₁₅H₁₅BrN₂O₂

Buist, Amanda R.Kennedy, Alan R.Shankland, Kenneth Shankland, Norman Spillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=5.0943(11)Å b=11.110(2)Å c=26.065(5)Å

α=90.00° β=91.646(19)° γ=90.00°

C₁₅H_15.5Cl_0.5N₂O_2.5

C₁₅H_15.5Cl_0.5N₂O_2.5

Buist, Amanda R.Kennedy, Alan R.Shankland, Kenneth Shankland, Norman Spillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=29.4803(17)Å b=4.9462(2)Å c=21.6558(13)Å

α=90.00° β=119.462(8)° γ=90.00°

Remacemide hydrochloride salt

C₁₇H₂₁N₂O_,Cl

Lewis, Gareth R.Steele, Gerry McBride, Lorraine Florence, Alastair J.Kennedy, Alan R.Shankland, Norman David, William I. F.Shankland, Kenneth Teat, Simon J.

Crystal Growth & Design (2005) 5, 2 427

a=10.660(2)Å b=8.712(2)Å c=17.624(3)Å

α=90.00° β=90.770(18)° γ=90.00°

C₁₅H₁₃ClN₂O

C₁₅H₁₃ClN₂O

Buist, Amanda R.Kennedy, Alan R.Shankland, Kenneth Shankland, Norman Spillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=14.1099(3)Å b=17.4778(3)Å c=5.3403(2)Å

α=90.00° β=90.00° γ=90.00°

C₁₃H₁₈O₂

C₁₃H₁₈O₂

Shankland, Norman Florence, Alastair J.Cox, Philip J.Sheen, David B.Love, Steve W.Stewart, Neil S.Wilson, Chick C.

Chemical Communications (1996) 7 855-856

a=14.397(8)Å b=7.818(4)Å c=10.506(6)Å

α=90° β=99.70(3)° γ=90°